2[2]Suarez DL, Perdue ML, Cox N, et al. Comparisons of highly virulent H5N1 influenza A viruses isolated form humans and chickens from Hong Kong. J Virok,1998,72(8):6678-88.
3[3]Guo YJ, Krauss S, Senne DA, et al. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology,2000,267(2) :279-88.
5[6]Conne P, Gauthey L, Vernet P, et al. Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients.Vaccine, 1997,15(15): 1675-1679.
6[7]de Jong JC, Beyer WE, Palache AM, et al. Mismatch between the 1997/1998 influenza vaccine = induced antibody response to this strain in the elderly. J Med Virol,2000,61(1) :94-99.
7[8]Webster RG. Immunity to influenza in the elderly. Vaccine,2000,18(16): 1686-1689.
8[9]McElhaney HE, Gravenstein S, Upshaw CM, et al. Immune response to influenza vaccination in institutionalized elderly: effect on different Tcell subsets. Vaccine, 1998,16(4) :403-409.
9[10]Hoskins TW, Davis JR, Smith, etal. Assessment of inactivated influenza- A vaccine after three outbreaks of influenza A at Christ' s Hospital, Lancet, 1979,1: 33-35.
10[11]Gambaryan AS, Robertson JS, Matrisivich MN. Effects of egg-adaptation on the receptor- binding properties of human influenza A and B viruses. Virology, 1999,258(2) :232-239
